| Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease. | |
| | |
MedLine Citation:
|
PMID: 8730344 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effects of calcium channel blockers (CCBs) and angiotensin converting enzyme (ACE) inhibitors on blood pressure and the progression of renal dysfunction were compared in hypertensive patients with polycystic kidney disease (PKD). Twenty-six patients with PKD and hypertension who had been treated with other antihypertensive agents, such as diuretics, beta-blockers, or alpha-methyldopa, were followed up for two years, during which their blood pressure and renal function were monitored. Patients were divided into two groups classified according to the type of antihypertensive agents given. Group 1 (n = 14) received CCBs, while group 2 (n = 12) received ACE inhibitors. No significant differences were found in their blood pressure control and serum creatinine levels throughout the study. The creatinine clearances were decreased in both groups. However, the decreases in creatinine clearance were smaller (p < 0.05) in the group treated with CCBs. In addition, two patients in group 2 showed rapid increases in serum creatinine. Our data suggest that CCBs reduced blood pressure effectively and preserved renal function in PKD patients at least as well as ACE inhibitors. |
| | |
Authors:
|
Y Kanno; H Suzuki; H Okada; T Takenaka; T Saruta |
Related Documents
:
|
14564134 - The differences between ace inhibitor-treated and calcium channel blocker-treated hyper... 3534854 - Influence of captopril on intracellular ions--a possible mode of action. 18679784 - Pulsatile mechanical pressure promotes angiotensin-converting enzyme expression in aort... 7018794 - Effect of the converting-enzyme inhibitor sq 14 225 (captopril) in early one-kidney, on... 3177854 - Blood pressure response of neonates to tracheal intubation. 7589654 - Elevated tubal perfusion pressures during selective salpingography are highly suggestiv... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: QJM : monthly journal of the Association of Physicians Volume: 89 ISSN: 1460-2725 ISO Abbreviation: QJM Publication Date: 1996 Jan |
Date Detail:
|
Created Date: 1996-10-24 Completed Date: 1996-10-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9438285 Medline TA: QJM Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 65-70 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine, Keio University, Tokyo, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin-Converting Enzyme Inhibitors
/
therapeutic use* Antihypertensive Agents / therapeutic use* Blood Pressure / drug effects Calcium Channel Blockers / therapeutic use* Captopril / therapeutic use Enalapril / therapeutic use Female Humans Hypertension / complications, drug therapy* Male Middle Aged Nicardipine / therapeutic use Nifedipine / therapeutic use Polycystic Kidney Diseases / complications* |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Calcium Channel Blockers; 21829-25-4/Nifedipine; 55985-32-5/Nicardipine; 62571-86-2/Captopril; 75847-73-3/Enalapril |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherap...
Next Document: Bacterial meningitis in patients with nasopharyngeal carcinoma.